Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen Uses, Dosage, Side Effects and more
Neisseria meningitidis serogroup B recombinant lp2086 a05 protein variant antigen is a sterile vaccine for intramuscular injection indicated for the active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. It is contained in the suspension of Trumenba, which is a vaccine is composed of two recombinant lipidated factor H binding protein (fHBP) variants from N. meningitidis serogroup B, one from fHBP subfamily A and one from subfamily B (A05 and B01, respectively).
| Trade Name | Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen |
| Generic | Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen |
| Type | |
| Groups | Approved |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
